Olga Kubassova, PhD

Nuclear Medicine
How medical imaging can accelerate drug development
It can take 15 years to get a drug candidate from the lab to approval. Could medical imaging speed up that process? Olga Kubassova, PhD, of Image Analysis Group explains how imaging modalities such as MRI, CT, and PET are helping to track biomarkers in clinical studies, potentially bringing lifesaving therapies to patients more quickly.
January 21, 2019
2019 01 19 01 32 0491 Research Lab Modern 400
Page 1 of 1
Top Stories
Astro Sf
Radiation Oncology/Therapy
ASTRO: Short prostate SBRT reduces side effects, but not PSA levels
Study findings offer new evidence to help guide treatment decisions for patients with localized prostate cancer, researchers said.
Img 2757
Radiation Oncology/Therapy
ASTRO: STAR has role in managing VT in cardiac patients
Colorectal Cancer
CT
5-year CTC screening interval is appropriate for colorectal cancer
Astro Sf
MRI
ASTRO: Daily MRgRT recontouring improves prostate treatment outcomes
Digital Innovations Shaping the Future of Radiology
Sponsor Content
Digital Innovations Shaping the Future of Radiology
More in Home
ASTRO: Short prostate SBRT reduces side effects, but not PSA levels
By Kate Madden Yee
Study findings offer new evidence to help guide treatment decisions for patients with localized prostate cancer, researchers said.
October 1, 2025
Astro Sf
ASTRO: STAR has role in managing VT in cardiac patients
By Amerigo Allegretto
Stereotactic arrhythmia radiotherapy (STAR) is safe and effective for treating refractory VT compared to repeat catheter ablation.
October 1, 2025
Img 2757
5-year CTC screening interval is appropriate for colorectal cancer
By Kate Madden Yee
The study's findings add to an ongoing conversation about the use of CTC for colorectal cancer screening.
September 30, 2025
Colorectal Cancer
ASTRO: Daily MRgRT recontouring improves prostate treatment outcomes
By Kate Madden Yee
Daily online adaptive recontouring is associated with clinically meaningful benefit in patient-reported quality of life measures.
September 30, 2025
Astro Sf
ASTRO: Radiation therapy comparable to surgery for early-stage lung cancer
By Will Morton
At 10 years, overall survival was virtually identical between patients treated with radiation therapy versus surgery.
September 30, 2025
Moscone Center
CT use in the ED has more than doubled over a decade
By Kate Madden Yee
The finding could be due to the "evolving role of CT in ED care delivery," researchers noted.
September 30, 2025
Emergency Entrance
ASTRO: Proton therapy shows promise in breast cancer treatment
By Amerigo Allegretto
Proton radiation achieves similar health-related quality of life measures compared to photon radiation in breast cancer patients.
September 30, 2025
Img 2757
Israeli radiologist discusses response to Oct. 7 attacks
By Will Morton
Workflow and staffing changes led to a reduction in CT turnaround times from 54 minutes to 27 minutes after the October 7, 2023 attack.
September 30, 2025
Representative injuries in patients from the mass casualty incident of October 7, 2023. (A) Axial CT scan at the pelvic level in a 34-year-old male patient shows multiple shrapnel fragments in the pelvis, resulting in fractures of the pelvic bones and lumbar vertebrae (not visible on this image). (B) Coronal reconstruction of a head CT scan in a 20-year-old male patient shows penetrating trauma to the left eyeball with a retained bullet in the orbital cavity. (C) Radiograph of a fetus delivered by emergency cesarean section from a critically injured mother shows a left pneumothorax and catheter in place. (D) Radiograph in a 25-year-old female patient shows a comminuted fracture in the tibial metaphysis with fragment displacement and multiple bony fragments in the surrounding soft tissues.
ASTRO: Trial suggests post-operative RT in high-risk bladder cancer
By Liz Carey
Moderate doses of radiation therapy after bladder removal surgery cut rates of new pelvic cancer, according to researchers.
September 30, 2025
Moscone Center Astro
ASTRO: Lu-177 PNT2002 added to SBRT delays prostate cancer progression
By Will Morton
Two cycles of lutetium-177 PNT2002 before stereotactic body radiation therapy (SBRT) significantly improved progression-free survival.
September 29, 2025
Moscone Center Astro
ASTRO: Contemporary IMRT comparable to proton therapy for throat cancer
By Liz Carey
Phase III U.K. TORPEdO trial investigated proton beam therapy for reducing long-term treatment-related toxicities.
September 29, 2025
Moscone Center Astro
NAPT survey results show promise for proton therapy adoption
By Amerigo Allegretto
Proton therapy continues to experience increased clinical use, but barriers to care continue to limit its potential.
September 29, 2025
Survey Form 400
Page 1 of 174
Next Page